Ouro Fino Saúde Animal Participações S.A. (OFSA3) Earnings Call Transcripts

Ouro Fino Saúde Animal Participações S.A.'s Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, Ouro Fino Saúde Animal reported a robust 32% year-over-year revenue growth, reaching BRL 400 million, driven by strong performance in both production and companion animal segments. The company's net profit also saw significant improvement, reflecting effective cost management and product launches. Management maintained a positive outlook for the year, emphasizing ongoing innovation and international expansion efforts, particularly in the Southern Cone and Asia.

Reported metrics

Guidance from management

Management expressed confidence in continued growth and profitability, emphasizing a focus on innovation and international expansion. They indicated a strategic plan for the next five years, aiming for sustained performance improvements.

What management said

Hello. Good morning. Welcome to this teleconference of the first quarter of 2026 of Ouro Fino Saúde Animal. My name is Marcelo Silva. I am the CFO. And together with Kleber Gomes, our CEO, we are going to bring you the highlights of the company in the quarter, our forecast for the year. So I will hand the floor to Kleber Gomes that is going to do the official opening.

Thank you, Marcelo. And while we don't have any questions, I would like to highlight that as said, the first quarter in our sector is historically weaker, but we are very happy because ours shows that the year was very positive.

What analysts pressed on

Analysts raised questions about the impact of inflation on the companion animal segment and the potential effects of geopolitical tensions on logistics and costs. There were concerns regarding the sustainability of growth in a challenging market environment.

Main topics on the call

• Strong Revenue Growth — Ouro Fino achieved a 32% increase in net revenue compared to the same quarter last year, attributed to successful product launches and market demand. CEO Kleber Gomes stated, "we had a very good growth, a very strong gro...
• Improved Profitability — The gross margin improved by 5.4 percentage points, reaching 53.9%, due to efficient operations and successful product launches. This was underscored by CFO Marcelo Da Silva, who noted, "we grew EBITDA more than the gros...
• International Expansion Strategy — Management outlined plans for rapid expansion into the Southern Cone and Asia, focusing on regulatory compliance and partnerships with local distributors. Kleber Gomes mentioned, "we are on a very strong agenda on the co...
• Challenges in Companion Animal Segment — Despite overall growth, the companion animal market remains challenging, with growth at 23.4% amid broader market retraction. Marcelo Da Silva acknowledged that "the market has this humanization of the way of managing Co...

Read the full Ouro Fino Saúde Animal Participações S.A. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 29 Ouro Fino Saúde Animal Participações S.A. earnings call transcripts on record, spanning February 12, 2020 to August 7, 2026. Based on this history, Ouro Fino Saúde Animal Participações S.A. reports quarterly. The most recent call on file is dated August 7, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

OFSA3

Exchange

BOVESPA

Country

BR

Sector

Health Care

Industry

Pharmaceuticals

Calls on record

29

First call

February 12, 2020

Most recent

August 7, 2026

Reporting cadence

quarterly